Model Cancer Systems and How Clinical Trials will be impacted

CCIL Research Program Leader, Brendan Harley, is studying glioblastoma, an aggressive form of brain cancer. Harley's lab, working collaboratively across campus, is developing platforms that are helping scientists better understand this deadly disease and how to develop better cancer treatments.